Galanin-like Peptide (Human, 1-60)

Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-Asp-Gly-Lys-Arg-Glu-Thr-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-His-Pro-Pro-Gln-Pro-Ser
: (M.W. 6500.3) C₂₉₂H₄₅₁N₈₃O₈₄S
: Ligand for Galanin Receptor 2/Target Peptide for Feeding Regulation by Leptin

Package	Price(Yen)	Availability	Quantity
Vial 0.1 mg	29,000	Ships within 1-3 business days
バルク見積もり

Solubility: H₂O (50 μM)

T. Ohtaki, S. Kumano, Y. Ishibashi, K. Ogi, H. Matsui, M. Harada, C. Kitada, T. Kurokawa, H. Onda, and M. Fujino, J. Biol. Chem., 274, 37041 (1999). (Original)
Y. Matsumoto, T. Watanabe, Y. Adachi, T. Itoh, T. Ohtaki, H. Onda, T. Kurokawa, O. Nishimura, and M. Fujino, Neurosci. Lett., 322, 67 (2002). (Stimulation of Food Intake)
H.-M. Tan, A.L. Gundlach, and M.J. Morris, Neuropeptides, 39, 333 (2005). (Pharmacol.; Exaggerated Feeding Response)
A. Juréus, M.J. Cunningham, M.E. Mcclain, D.K. Clifton, and R.A. Steiner, Endocrinology, 141, 2703 (2000). (Pharmacol.)
A.J. Kastin, V. Akerstrom, and L. Hackler, Neuroendocrinology, 74, 423 (2001). (Brain Entry)
A.L. Gundlach, Eur. J. Pharmacol., 440, 255 (2002). (Review)
P.S. Man and C.B. Lawrence, Neuropharmacology, 55 (2008). (Review)
C.B. Lawrence, Physiol. Behav., 97, 515 (2009). (Review)
J.N. Crawley, and G.L. Wenk, Trends Neurosci., 12, 278 (1989). (Review)
T. Bartfai, G. Fisone, and Ü Langel, Trends Pharmacol. Sci., 13, 312 (1992). (Review)